These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35511410)

  • 1. Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1.
    Ruidas B; Sur TK; Das Mukhopadhyay C; Sinha K; Som Chaudhury S; Sharma P; Bhowmick S; Majumder R; Saha A
    Breast Cancer; 2022 Jul; 29(4):748-760. PubMed ID: 35511410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
    Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
    Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.
    Linher-Melville K; Zantinge S; Sanli T; Gerstein H; Tsakiridis T; Singh G
    BMC Cancer; 2011 Feb; 11():56. PubMed ID: 21294903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria fission accentuates oxidative stress in hyperglycemia-induced H9c2 cardiomyoblasts in vitro by regulating fatty acid oxidation.
    Song X; Fan C; Wei C; Yu W; Tang J; Ma F; Chen Y; Wu B
    Cell Biol Int; 2024 Sep; 48(9):1378-1391. PubMed ID: 38922770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of β-oxidation.
    Yao CH; Liu GY; Wang R; Moon SH; Gross RW; Patti GJ
    PLoS Biol; 2018 Mar; 16(3):e2003782. PubMed ID: 29596410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.
    Park JH; Vithayathil S; Kumar S; Sung PL; Dobrolecki LE; Putluri V; Bhat VB; Bhowmik SK; Gupta V; Arora K; Wu D; Tsouko E; Zhang Y; Maity S; Donti TR; Graham BH; Frigo DE; Coarfa C; Yotnda P; Putluri N; Sreekumar A; Lewis MT; Creighton CJ; Wong LC; Kaipparettu BA
    Cell Rep; 2016 Mar; 14(9):2154-2165. PubMed ID: 26923594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
    Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
    Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity.
    Yu L; Wei W; Lv J; Lu Y; Wang Z; Cai C
    Cancer Lett; 2024 Nov; 604():217271. PubMed ID: 39306229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl-CoA.
    Ngo J; Choi DW; Stanley IA; Stiles L; Molina AJA; Chen PH; Lako A; Sung ICH; Goswami R; Kim MY; Miller N; Baghdasarian S; Kim-Vasquez D; Jones AE; Roach B; Gutierrez V; Erion K; Divakaruni AS; Liesa M; Danial NN; Shirihai OS
    EMBO J; 2023 Jun; 42(11):e111901. PubMed ID: 36917141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.
    Reis LMD; Adamoski D; Ornitz Oliveira Souza R; Rodrigues Ascenção CF; Sousa de Oliveira KR; Corrêa-da-Silva F; Malta de Sá Patroni F; Meira Dias M; Consonni SR; Mendes de Moraes-Vieira PM; Silber AM; Dias SMG
    J Biol Chem; 2019 Jun; 294(24):9342-9357. PubMed ID: 31040181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression.
    Yang JH; Kim NH; Yun JS; Cho ES; Cha YH; Cho SB; Lee SH; Cha SY; Kim SY; Choi J; Nguyen TM; Park S; Kim HS; Yook JI
    Life Sci Alliance; 2020 Jul; 3(7):. PubMed ID: 32487689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPT1 Mediated Ionizing Radiation-Induced Intestinal Injury Proliferation via Shifting FAO Metabolism Pathway and Activating the ERK1/2 and JNK Pathway.
    Liu HX; Zhao H; Xi C; Li S; Ma LP; Lu X; Yan J; Tian XL; Gao L; Tian M; Liu QJ
    Radiat Res; 2022 Nov; 198(5):488-507. PubMed ID: 36351324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mitochondrial activity in BMP7-treated brown adipocytes, due to increased CPT1- and CD36-mediated fatty acid uptake.
    Townsend KL; An D; Lynes MD; Huang TL; Zhang H; Goodyear LJ; Tseng YH
    Antioxid Redox Signal; 2013 Jul; 19(3):243-57. PubMed ID: 22938691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway.
    Zheng P; Wu H; Gu Y; Li L; Hu R; Ma W; Bian Z; Liu N; Yang D; Chen X
    Biomed Pharmacother; 2023 Jan; 157():114024. PubMed ID: 36402030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers.
    Aiderus A; Black MA; Dunbier AK
    BMC Cancer; 2018 Aug; 18(1):805. PubMed ID: 30092766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer.
    Guo X; Wang A; Wang W; Wang Y; Chen H; Liu X; Xia T; Zhang A; Chen D; Qi H; Ling T; Piao HL; Wang HJ
    Mol Oncol; 2021 Feb; 15(2):642-656. PubMed ID: 33207079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics.
    Lu R; Hong J; Fu T; Zhu Y; Tong R; Ai D; Wang S; Huang Q; Chen C; Zhang Z; Zhang R; Guo H; Li B
    Adv Sci (Weinh); 2024 Jun; 11(24):e2308945. PubMed ID: 38627980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
    Qu Q; Zeng F; Liu X; Wang QJ; Deng F
    Cell Death Dis; 2016 May; 7(5):e2226. PubMed ID: 27195673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer.
    Han J; Qu H; Han M; Ding Y; Xie M; Hu J; Chen Y; Dong H
    Oncogene; 2021 Jan; 40(4):833-847. PubMed ID: 33273726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Fatty Acid β-Oxidation Inhibition Promotes Glucose Utilization and Protein Deposition through Energy Homeostasis Remodeling in Fish.
    Li LY; Li JM; Ning LJ; Lu DL; Luo Y; Ma Q; Limbu SM; Li DL; Chen LQ; Lodhi IJ; Degrace P; Zhang ML; Du ZY
    J Nutr; 2020 Sep; 150(9):2322-2335. PubMed ID: 32720689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.